Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 23;2(7):e211693.
doi: 10.1001/jamahealthforum.2021.1693. eCollection 2021 Jul.

National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019

Aaron Troy  1   2 , Timothy S Anderson  3   4   5
Affiliations

National Trends in Use of and Spending on Oral Anticoagulants Among US Medicare Beneficiaries From 2011 to 2019

Aaron Troy et al. JAMA Health Forum. .

Abstract

This cross-sectional study examines patterns of use of direct oral anticoagulants and their association with Medicare spending.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Anderson reports research grants from the National Institute on Aging and American College of Cardiology outside of the submitted work and honoraria from Alosa Health. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Oral Anticoagulant Use and Estimated Spending in Medicare Part D From 2011 to 2019
All prices presented in 2019 dollars after adjustment using the Consumer Price Index. Spending per year includes Medicare, plan, and beneficiary payments, accounting for branded medication discounts using the brand-name summed-discounts approach (eMethods in the Supplement). DOAC indicates direct oral anticoagulant.
Figure 2.
Figure 2.. Estimated Annual Medicare Part D Spending on Anticoagulation per Beneficiary With Atrial Fibrillation From 2011 to 2019
All costs presented in 2019 dollars after adjustment using Consumer Price Index. Estimated total per beneficiary annual spending calculated as total Medicare spending per dosage unit multiplied by 365 days and by the number of pills per daily dose based on standard nonvalvular atrial fibrillation dosing. Spending per year includes Medicare, plan, and beneficiary payments, accounting for branded medication discounts using the brand-name summed-discounts approach (eMethods in the Supplement). NA indicates not applicable.
See this image and copyright information in PMC

References

    1. Dayoub EJ, Ross JS, Shah ND, Dhruva SS. Evolution of Medicare formulary coverage changes for antithrombotic therapies after guideline updates. Circulation. 2019;140(14):1227-1230. doi:10.1161/CIRCULATIONAHA.119.040580 - DOI - PubMed
    1. Desai NR, Krumme AA, Schneeweiss S, et al. . Patterns of initiation of oral anticoagulants in patients with atrial fibrillation—quality and cost implications. Am J Med. 2014;127(11):1075-1082.e1. doi:10.1016/j.amjmed.2014.05.013 - DOI - PubMed
    1. US Centers for Medicare & Medicaid Services . Medicare Part D drug spending dashboard & data. Accessed January 25, 2020. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Tren...
    1. Feldman WB, Rome BN, Raimond VC, Gagne JJ, Kesselheim AS. Estimating rebates and other discounts received by Medicare Part D. JAMA Health Forum. 2021;2(6):e210626. doi:10.1001/jamahealthforum.2021.0626 - DOI - PubMed
    1. Shah A, Shewale A, Hayes CJ, Martin BC. Cost-effectiveness of oral anticoagulants for ischemic stroke prophylaxis among nonvalvular atrial fibrillation patients. Stroke. 2016;47(6):1555-1561. doi:10.1161/STROKEAHA.115.012325 - DOI - PubMed